Injectable matrix metalloproteinase-responsive nanoparticle hydrogel scaffold for sustained local drug delivery in fibrous dysplasia

Authors:

Abstract
RANKL inhibition has shown significant therapeutic benefit in fibrous dysplasia (FD). However, sustained RANKL inhibition is required to maintain its therapeutic effect. Moreover, disease rebound following discontinuation of denosumab, a human monoclonal RANKL antibody, poses a major clinical challenge to FD treatment, thereby highlighting the need for strategies that preserve lesion-level efficacy while limiting systemic exposure. Matrix metalloproteinases (MMPs), which are essential for osteoclast function and bone remodeling, have emerged as a key pathogenic pathway in FD. Lesion profiling revealed elevated expression of MMP-9, -13, and -14 in osteoclast-rich FD lesions, with dynamic regulation in response to pharmacologic RANKL inhibition and withdrawal. We hypothesized that MMPs may serve as lesion-associated biological cues for localized drug delivery in FD. We developed an injectable, sustained, and MMP-responsive local drug delivery system by integrating triglycerol monostearate nanoparticles within a dynamically crosslinked hyaluronic acid-based hydrogel scaffold (HPD/TGMS). To validate this strategy, the small-molecule RANKL inhibitor AS2676293 was loaded into TGMS to generate HPD/TGMS@A. Matrix metalloproteinase-mediated cleavage of the ester linkage in TGMS enabled protease-responsive drug release, further regulated by hydrogel-constrained perilesional retention. HPD/TGMS@A demonstrated favorable injectability, self-healing behavior, cytocompatibility, and MMP-dependent anti-osteoclastic activity in vitro. HPD/TGMS@A significantly attenuated FD lesion progression and improved bone microarchitecture in a GNASR201C knock-in FD mouse model through perilesional injection. Altogether, these findings establish HPD/TGMS as a localized, lesion-responsive drug delivery strategy in FD.
Funding Information
  • National Regional Joint Key Fund (U24A20712)
  • Sichuan University internal grants (23H0924)
  • National Natural Science Foundation of China (82470940)
  • National Natural Science Foundation of China (82371002)
  • National Natural Science Foundation of China (82571136)
  • National Natural Science Foundation of China (82330029)
  • National Natural Science Foundation of China (2024NSFSC0540)
  • National Natural Science Foundation of China (2025NSFCTD0026)

This publication has 33 references indexed in Scilit: